Calyxt (CLXT) Given Media Sentiment Rating of 0.10

News articles about Calyxt (NASDAQ:CLXT) have trended somewhat positive this week, according to Accern. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Calyxt earned a news sentiment score of 0.10 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.3360211710106 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Calyxt (NASDAQ CLXT) opened at 21.87 on Tuesday. The firm’s market cap is $428.65 million. Calyxt has a 12-month low of $9.26 and a 12-month high of $29.45. The stock has a 50 day moving average of $16.12 and a 200 day moving average of $16.44.

Several research firms have recently weighed in on CLXT. Citigroup Inc. began coverage on shares of Calyxt in a report on Tuesday, August 15th. They issued a “buy” rating and a $16.00 price target for the company. Wells Fargo & Company began coverage on shares of Calyxt in a report on Monday, August 14th. They issued an “outperform” rating and a $17.00 price target for the company. Finally, Jefferies Group LLC began coverage on shares of Calyxt in a report on Monday, August 14th. They issued a “buy” rating and a $16.00 price target for the company.

WARNING: This piece was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.chaffeybreeze.com/2017/09/19/calyxt-clxt-given-media-sentiment-rating-of-0-10.html.

About Calyxt

Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.

Insider Buying and Selling by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply